Cargando…
Risk of hernia-related complications after transjugular intrahepatic portosystemic shunt creation in patients with pre-existing ventral abdominal hernias: 15-year experience at a quaternary medical center
OBJECTIVE: Transjugular intrahepatic portosystemic shunt (TIPS) placement is used to treat the sequelae of portal hypertension, including refractory variceal bleeding, ascites and hepatic hydrothorax. However, hernia-related complications such as incarceration and small bowel obstruction can occur a...
Autores principales: | McDaniel, Charles, Bell, Ruth, Farha, Natalie, Vozzo, Catherine, Bullen, Jennifer, Rosen, Michael, Romero-Marrero, Carlos, Partovi, Sasan, Kapoor, Baljendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943763/ https://www.ncbi.nlm.nih.gov/pubmed/35318192 http://dx.doi.org/10.1136/bmjgast-2022-000876 |
Ejemplares similares
-
Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes
por: Helzberg, James H, et al.
Publicado: (2022) -
Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience
por: Vozzo, Catherine F, et al.
Publicado: (2019) -
Advanced portal venous access techniques for transjugular intrahepatic portosystemic shunt placement
por: Partovi, Sasan, et al.
Publicado: (2021) -
Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt
por: Yang, Chongtu, et al.
Publicado: (2021) -
First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan
por: Tsuruya, Kota, et al.
Publicado: (2023)